|
    ACST U.S.: Nasdaq

    Acasti Pharma Inc.

    ACSTUS
    After Hours
    Last Updated: Sep 17, 2021 7:34 p.m. EDT Delayed quote

    $ 2.1600

    -0.03 -1.37%
    After Hours Volume: 3.06K
    Close Chg Chg %
    $2.1900 0.0200 0.92%
    Advanced Charting
    Volume: 416.99K 65 Day Avg: 1.25M
    33% vs Avg
    2.1400 Day Range 2.2200
    1.3680 52 Week Range 9.7600

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ACST Overview

    Performance

    5 Day
    • -6.41%
    1 Month
    • -33.72%
    3 Month
    • -45.78%
    YTD
    • -15.77%
    1 Year
    • 26.56%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    Acasti Pharma downgraded to neutral from buy at B. Riley FBR

    Acasti Pharma downgraded to perform from outperform at Oppenheimer

    Acasti Pharma upgraded to buy from neutral at B. Riley FBR

    Acasti Pharma stock price target cut to $2 from $8 at B. Riley FBR

    Acasti Pharma downgraded to neutral from buy at B. Riley FBR

    Amarin's stock surges, as rival drugs from AstraZeneca, Acasti disappoint

    Read full story

    Amarin Stock Is Surging as Rival Makers of Fish-Oil Heart Drugs Fall Short

    Acasti Pharma started at outperform with $7 stock price target at Oppenheimer

    Acasti Pharma: Low Chance of a Rebound

    on TipRanks.com

    Why Shares of Acasti Pharma Slumped Tuesday

    on Motley Fool

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

    on InvestorPlace.com

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

    on InvestorPlace.com

    Wednesday’s Pre-Market: Here’s What You Need to Know Before the Market Opens

    on TipRanks.com

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

    on InvestorPlace.com

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

    on InvestorPlace.com

    Wait for Acasti Pharma Stock to Fall Further Before Buying

    on InvestorPlace.com

    Acasti Pharma Stock Is Only Ideal for a Short-Term Trade

    on InvestorPlace.com

    ACST Stock Alert: 13 Things for Acasti Pharma Investors to Know as Shares Rocket Monday

    on InvestorPlace.com

    Acasti (ACST) Moves to Buy: Rationale Behind the Upgrade

    on Zacks.com

    ACST Stock: 13 Things to Know as Acasti Pharma Shares Soar 100%

    on InvestorPlace.com

    AMRN Stock News: Why Amarin Shares Are Climbing Today

    on InvestorPlace.com

    Zynerba Pharmaceuticals (ZYNE) Jumps: Stock Rises 7.7%

    on Zacks.com

    What Makes Acasti (ACST) a New Buy Stock

    on Zacks.com

    FDA Advisory Committee Recommends Mallinckrodt's Trelipressin

    on Zacks.com

    FDA Advisory Committee to Review Mallinckrodt'sTerlipressin

    on Zacks.com

    Why an Appeals Court May Hold Key to Amarin Stock Future

    on 247WallSt.com

    AstraZeneca to End Phase III Study on Fish Oil Heart Drug

    on Zacks.com

    Acasti Pharma Inc.

    Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Laval, Canada.

    Competitors

    Name Chg % Market Cap
    Ono Pharmaceutical Co. Ltd. ADR 0.85% $12.27B
    Omeros Corp. 1.40% $998.68M
    Competitor Data Provided ByCapital Cube Logo